ZEMAIRA
alpha-1-proteinase inhibitor human kit · KIT · Fisher Clinical Services Inc.
Zemaira is an intravenous medication used to treat alpha-1 antitrypsin deficiency, a genetic condition that can damage the lungs and liver. It works by replacing the missing or low levels of a protective protein in your body.
Key Facts
- Brand Name
- ZEMAIRA
- Generic Name
- alpha-1-proteinase inhibitor human kit
- NDC Code (Product)
57516-110- Manufacturer
- Fisher Clinical Services Inc.
- Dosage Form
- KIT
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125078
- Marketing Start
- 07/31/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is ZEMAIRA used for?
Zemaira is an intravenous medication used to treat alpha-1 antitrypsin deficiency, a genetic condition that can damage the lungs and liver. It works by replacing the missing or low levels of a protective protein in your body.
Is ZEMAIRA a controlled substance?
ZEMAIRA is not classified as a controlled substance by the DEA.
What is the generic name for ZEMAIRA?
The generic name for ZEMAIRA is alpha-1-proteinase inhibitor human kit. There are no other listed brand versions of alpha-1-proteinase inhibitor human kit.
What is the NDC code for ZEMAIRA ?
The NDC (National Drug Code) for ZEMAIRA is 57516-110, listed by Fisher Clinical Services Inc..
Other ZEMAIRA Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)